LA
AVXL icon

LexAurum Advisors’s Anavex Life Sciences AVXL Stock Holding History

LexAurum Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168K Sell
65,050
-2,400
-4% -$7.1K 0.02% 413
2026
Q1 		$207K Buy
+67,450
New +$292K 0.03% 378

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LexAurum Advisors's AVXL Position: Q2 2026 in Review

LexAurum Advisors reduced its Anavex Life Sciences (AVXL) stake by 3.6% in Q2 2026, selling an estimated $7.1K and leaving 65,050 shares worth $168K. The position accounts for 0.02% of the portfolio, ranked #413.

LexAurum Advisors first reported a position in AVXL in Q1 2026 and has held it in 2 quarters since. The position peaked at $207K in Q1 2026. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • LexAurum Advisors held 65,050 shares of Anavex Life Sciences worth $168K as of Q2 2026.
  • LexAurum Advisors sold 2,400 Anavex Life Sciences shares in Q2 2026, an estimated $7.1K.
  • Anavex Life Sciences made up 0.02% of LexAurum Advisors's portfolio in Q2 2026, its #413 holding.
  • LexAurum Advisors first reported a position in Anavex Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • LexAurum Advisors's Anavex Life Sciences position peaked at $207K in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on LexAurum Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.